How patients being treated for non-small cell lung cancer value treatment benefit despite side effects.

ABSTRACT:

Purpose

To describe symptoms and side effects experienced by patients with advanced non-small cell lung cancer (NSCLC), assess how patients allocate sensations (i.e. symptoms or side effects) to either the disease or its treatment, and evaluate how patients balance side effects with treatment benefits.

Methods

Qualitative sub-studies were conducted as part of two clinical trials in patients treated for advanced NSCLC (AURA [NCT01802632]; ARCTIC [NCT02352948]).

Results

Interviews were conducted with 23 patients and 19 patients in the AURA and ARCTIC sub-studies, respectively. The most commonly experienced symptoms/side effects were respiratory (81% of patients), digestive (76%), pain and discomfort (76%), energy-related (71%), and sensory (62%). Patients identified a s

SUBMITTER: Martin ML 

PROVIDER: S-EPMC8800875 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature